Clayton, Dubilier & Rice Sells AssuraMed in $2.1 billion transaction

NEW YORK - March 18, 2013 - We are pleased to announce the sale of AssuraMed to Cardinal Health in a transaction valued at approximately $2.1 billion.

Since Acquiring the company in 2010, CD&R worked closely with the company to strengthen the management team, accelerate patient acquisition, implement several gross margin initiatives including category management, upgrade systems and process disciplines, and pursue strategic acquisitions. The result was an 88% increase in EBITDA under the Firm's ownership (pro forma for the ISG acquisition and expected run-rate ISG synergies).


Clayton, Dubilier & Rice Sells AssuraMed in $2.1 billion transaction

NEW YORK - March 18, 2013 - We are pleased to announce the sale of AssuraMed to Cardinal Health in a transaction valued at approximately $2.1 billion.

Since Acquiring the company in 2010, CD&R worked closely with the company to strengthen the management team, accelerate patient acquisition, implement several gross margin initiatives including category management, upgrade systems and process disciplines, and pursue strategic acquisitions. The result was an 88% increase in EBITDA under the Firm's ownership (pro forma for the ISG acquisition and expected run-rate ISG synergies).